JT Stratford LLC Reduces Stock Position in Astera Labs, Inc. $ALAB

JT Stratford LLC cut its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 28.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,302 shares of the company’s stock after selling 4,441 shares during the quarter. JT Stratford LLC’s holdings in Astera Labs were worth $2,213,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the stock. Assetmark Inc. boosted its holdings in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Clearstead Trust LLC lifted its holdings in shares of Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after buying an additional 194 shares during the period. Manchester Capital Management LLC boosted its stake in shares of Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after buying an additional 283 shares during the last quarter. Finally, Whittier Trust Co. bought a new stake in shares of Astera Labs in the third quarter worth $55,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Trading Up 3.6%

Astera Labs stock opened at $113.77 on Thursday. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The firm has a market capitalization of $19.37 billion, a price-to-earnings ratio of 93.25, a P/E/G ratio of 2.16 and a beta of 1.74. The firm has a 50 day moving average of $154.84 and a 200 day moving average of $170.88.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s revenue for the quarter was up 91.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Activity

In other news, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares in the company, valued at $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer directly owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. This trade represents a 6.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 216,792 shares of company stock worth $26,777,569. 12.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. BNP Paribas Exane started coverage on Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating for the company. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $192.89.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.